Drug name - Locametz

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US11369590 AAA USA NOVARTIS PSMA binding ligand-linker conjugates and methods for using
Aug, 2028

(5 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Mar 23, 2025

Drugs and Companies using GALLIUM GA-68 GOZETOTIDE ingredient

Market Authorisation Date: 23 March, 2022

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
N/A POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.